For centuries, green tea has been revered in the Far East for its health benefits, but only recently have the claims been taken seriously and put to the test.
Green tea has long been suspected of having anti-cancer properties and a tea extract, called epigallocatechin gallate, has been investigated. Tests on two types of skin cancer showed 40 percent of tumours disappearing after one month of treatment, while an additional 20 to 30 percent shrank. This is the first time scientists have managed to make the tea extract effective at shrinking tumours in laboratory settings.
Dr Christine Dufès, a senior lecturer at the Strathclyde Institute of Pharmacy and Biomedical Sciences, who led the research, will discuss these highly promising results and how this laboratory-based research could open doors to new treatments to what is still one of the biggest killer diseases in many countries.
Presented by: Dr Christine Dufes, University of Strathclyde